international spinal research trust
international spinal research trust Company Information
Company Number
08409361
Website
www.spinal-research.orgRegistered Address
80 coleman street, london, EC2R 5BJ
Industry
Other human health activities
Telephone
02076538935
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
-0%
international spinal research trust Estimated Valuation
Pomanda estimates the enterprise value of INTERNATIONAL SPINAL RESEARCH TRUST at £777.5k based on a Turnover of £1.7m and 0.47x industry multiple (adjusted for size and gross margin).
international spinal research trust Estimated Valuation
Pomanda estimates the enterprise value of INTERNATIONAL SPINAL RESEARCH TRUST at £1.1m based on an EBITDA of £284k and a 4.05x industry multiple (adjusted for size and gross margin).
international spinal research trust Estimated Valuation
Pomanda estimates the enterprise value of INTERNATIONAL SPINAL RESEARCH TRUST at £5.1m based on Net Assets of £2.1m and 2.42x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
International Spinal Research Trust Overview
International Spinal Research Trust is a live company located in london, EC2R 5BJ with a Companies House number of 08409361. It operates in the other human health activities sector, SIC Code 86900. Founded in February 2013, it's largest shareholder is unknown. International Spinal Research Trust is a established, small sized company, Pomanda has estimated its turnover at £1.7m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
International Spinal Research Trust Health Check
Pomanda's financial health check has awarded International Spinal Research Trust a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
5 Weak
Size
annual sales of £1.7m, make it larger than the average company (£725.1k)
£1.7m - International Spinal Research Trust
£725.1k - Industry AVG
Growth
3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (5.3%)
-2% - International Spinal Research Trust
5.3% - Industry AVG
Production
with a gross margin of 35.8%, this company has a comparable cost of product (35.8%)
35.8% - International Spinal Research Trust
35.8% - Industry AVG
Profitability
an operating margin of 17.1% make it more profitable than the average company (6%)
17.1% - International Spinal Research Trust
6% - Industry AVG
Employees
with 13 employees, this is below the industry average (19)
13 - International Spinal Research Trust
19 - Industry AVG
Pay Structure
on an average salary of £50k, the company has a higher pay structure (£24.6k)
£50k - International Spinal Research Trust
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £127.5k, this is more efficient (£43.3k)
£127.5k - International Spinal Research Trust
£43.3k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - International Spinal Research Trust
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - International Spinal Research Trust
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - International Spinal Research Trust
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 61 weeks, this is less cash available to meet short term requirements (140 weeks)
61 weeks - International Spinal Research Trust
140 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 49.8%, this is a higher level of debt than the average (21.8%)
49.8% - International Spinal Research Trust
21.8% - Industry AVG
INTERNATIONAL SPINAL RESEARCH TRUST financials
International Spinal Research Trust's latest turnover from March 2023 is £1.7 million and the company has net assets of £2.1 million. According to their latest financial statements, International Spinal Research Trust has 13 employees and maintains cash reserves of £1.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,658,000 | 1,860,000 | 1,913,000 | 1,746,000 | 1,393,000 | 1,805,000 | 1,738,000 | 1,469,000 | 1,750,000 | 2,380,000 | 2,034,894 |
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 282,000 | 129,000 | 930,000 | 104,000 | -918,000 | 275,000 | 425,000 | 32,000 | 42,000 | 178,000 | 193,617 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 282,000 | 129,000 | 930,000 | 104,000 | -918,000 | 275,000 | 425,000 | 32,000 | 42,000 | 178,000 | 193,617 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 282,000 | 129,000 | 930,000 | 104,000 | -918,000 | 275,000 | 425,000 | 32,000 | 42,000 | 178,000 | 193,617 |
| Employee Costs | 650,000 | 472,000 | 381,000 | 459,000 | 457,000 | 440,000 | 406,000 | 487,000 | 625,000 | 699,000 | 701,990 |
| Number Of Employees | 13 | 9 | 8 | 8 | 457 | 440 | 406 | 8 | 9 | 14 | 14 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 1,000 | 4,000 | 7,000 | 3,000 | 3,000 | 5,000 | 0 | 0 | 1,000 | 3,911 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 1,356,000 | 1,356,000 | 1,163,000 | 448,000 | 382,000 | 374,000 | 368,000 | 272,000 | 277,000 | 1,239,000 | 458,376 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,356,000 | 1,357,000 | 1,167,000 | 455,000 | 385,000 | 377,000 | 373,000 | 272,000 | 277,000 | 1,240,000 | 462,287 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 700,000 | 560,000 | 337,000 | 299,000 | 139,000 | 173,000 | 109,000 | 271,000 | 202,000 | 136,000 | 32,662 |
| Cash | 1,580,000 | 1,486,000 | 2,139,000 | 2,264,000 | 2,291,000 | 2,482,000 | 2,205,000 | 1,813,000 | 2,077,000 | 1,549,000 | 2,495,912 |
| misc current assets | 590,000 | 774,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,870,000 | 2,820,000 | 2,476,000 | 2,563,000 | 2,430,000 | 2,655,000 | 2,314,000 | 2,084,000 | 2,279,000 | 1,685,000 | 2,528,574 |
| total assets | 4,226,000 | 4,177,000 | 3,643,000 | 3,018,000 | 2,815,000 | 3,032,000 | 2,687,000 | 2,356,000 | 2,556,000 | 2,925,000 | 2,990,861 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,359,832 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,328,000 | 1,164,000 | 1,685,000 | 1,536,000 | 1,453,000 | 820,000 | 776,000 | 929,000 | 1,466,000 | 1,602,000 | 70,301 |
| total current liabilities | 1,328,000 | 1,164,000 | 1,685,000 | 1,536,000 | 1,453,000 | 820,000 | 776,000 | 929,000 | 1,466,000 | 1,602,000 | 1,430,133 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 600,000 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 777,000 | 1,174,000 | 248,000 | 702,000 | 686,000 | 620,000 | 0 | 557,000 | 247,000 | 521,000 | 644,524 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 777,000 | 1,174,000 | 248,000 | 702,000 | 686,000 | 620,000 | 600,000 | 557,000 | 247,000 | 521,000 | 644,524 |
| total liabilities | 2,105,000 | 2,338,000 | 1,933,000 | 2,238,000 | 2,139,000 | 1,440,000 | 1,376,000 | 1,486,000 | 1,713,000 | 2,123,000 | 2,074,657 |
| net assets | 2,121,000 | 1,839,000 | 1,710,000 | 780,000 | 676,000 | 1,592,000 | 1,311,000 | 870,000 | 843,000 | 802,000 | 916,204 |
| total shareholders funds | 2,121,000 | 1,839,000 | 1,710,000 | 780,000 | 676,000 | 1,592,000 | 1,311,000 | 870,000 | 843,000 | 802,000 | 916,204 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 1,000 | 3,000 | 3,000 | 0 | 1,000 | 2,000 | 0 | 1,000 | 3,964,000 | ||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 140,000 | 223,000 | 38,000 | 160,000 | -34,000 | 64,000 | -162,000 | 69,000 | 66,000 | 103,338 | 32,662 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,359,832 | 1,359,832 |
| Accruals and Deferred Income | 164,000 | -521,000 | 149,000 | 83,000 | 633,000 | 44,000 | -153,000 | -537,000 | -136,000 | 1,531,699 | 70,301 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | -1,000 | 0 | -87,000 | 8,000 | 982,000 | ||
| Change in Investments | 0 | 193,000 | 715,000 | 66,000 | 8,000 | 6,000 | 96,000 | -5,000 | -962,000 | 780,624 | 458,376 |
| cash flow from investments | 0 | -193,000 | -715,000 | -66,000 | -9,000 | -6,000 | -183,000 | 13,000 | 1,944,000 | ||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | -600,000 | 600,000 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -397,000 | 926,000 | -454,000 | 16,000 | 66,000 | 620,000 | -557,000 | 310,000 | -274,000 | -123,524 | 644,524 |
| share issue | |||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | -397,000 | 926,000 | -454,000 | 16,000 | 68,000 | 26,000 | 59,000 | 305,000 | -275,000 | -415,728 | 1,367,111 |
| cash and cash equivalents | |||||||||||
| cash | 94,000 | -653,000 | -125,000 | -27,000 | -191,000 | 277,000 | 392,000 | -264,000 | 528,000 | -946,912 | 2,495,912 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 94,000 | -653,000 | -125,000 | -27,000 | -191,000 | 277,000 | 392,000 | -264,000 | 528,000 | -946,912 | 2,495,912 |
international spinal research trust Credit Report and Business Information
International Spinal Research Trust Competitor Analysis
Perform a competitor analysis for international spinal research trust by selecting its closest rivals and benchmarking them against 12 key performance metrics.
international spinal research trust Ownership
INTERNATIONAL SPINAL RESEARCH TRUST group structure
International Spinal Research Trust has no subsidiary companies.
Ultimate parent company
INTERNATIONAL SPINAL RESEARCH TRUST
08409361
international spinal research trust directors
International Spinal Research Trust currently has 10 directors. The longest serving directors include Mr William Shelton (Feb 2013) and Miss Elizabeth Blois (Feb 2013).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr William Shelton | 64 years | Feb 2013 | - | Director | |
| Miss Elizabeth Blois | 75 years | Feb 2013 | - | Director | |
| Mr Ian Curtis | 58 years | Jun 2015 | - | Director | |
| His Honour Peter Benson | 75 years | Jan 2019 | - | Director | |
| Mr Matthew Reeve | 44 years | Apr 2019 | - | Director | |
| Ms Tara Howell | England | 53 years | Jul 2020 | - | Director |
| Professor Robert Brownstone | England | 63 years | Jul 2021 | - | Director |
| Prof Sue Smith | 49 years | Feb 2022 | - | Director | |
| Dr David Baxter | 44 years | Mar 2022 | - | Director | |
| Mr Mark Lund | England | 65 years | Feb 2023 | - | Director |
P&L
March 2023turnover
1.7m
-11%
operating profit
283k
0%
gross margin
35.9%
+0.57%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
2.1m
+0.15%
total assets
4.2m
+0.01%
cash
1.6m
+0.06%
net assets
Total assets minus all liabilities
Similar Companies
international spinal research trust company details
company number
08409361
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
February 2013
age
11
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
80 coleman street, london, EC2R 5BJ
last accounts submitted
March 2023
international spinal research trust Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to international spinal research trust.
international spinal research trust Companies House Filings - See Documents
| date | description | view/download |
|---|
